X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (77) 77
index medicus (67) 67
cancer (52) 52
oncology (33) 33
animals (28) 28
electrochemistry (27) 27
metallothionein (27) 27
cell line, tumor (26) 26
apoptosis (24) 24
ellipticine (24) 24
dna (23) 23
male (22) 22
neuroblastoma (21) 21
biochemistry & molecular biology (20) 20
expression (20) 20
antineoplastic agents - pharmacology (19) 19
chemistry, analytical (17) 17
cytotoxicity (17) 17
tumors (16) 16
doxorubicin (15) 15
nanoparticles (15) 15
neoplasms - drug therapy (15) 15
chemistry (14) 14
prostate cancer (14) 14
resistance (14) 14
cell cycle (13) 13
cisplatin (13) 13
pharmacology & pharmacy (13) 13
zinc (13) 13
chemistry, multidisciplinary (12) 12
metabolism (12) 12
metallothionein - metabolism (12) 12
voltammetry (12) 12
biochemical research methods (11) 11
brdicka reaction (11) 11
breast-cancer (11) 11
female (11) 11
apoptosis - drug effects (10) 10
article (10) 10
cancer-cells (10) 10
cytochromes p450 (10) 10
drugs (10) 10
ellipticines - pharmacology (10) 10
gene expression (10) 10
in-vivo (10) 10
valproic acid (10) 10
activation (9) 9
analysis (9) 9
biology (9) 9
chemoresistance (9) 9
chemotherapy (9) 9
child (9) 9
drug delivery systems (9) 9
gene-expression (9) 9
in-vitro (9) 9
therapy (9) 9
biomarkers (8) 8
deoxyribonucleic acid--dna (8) 8
electrochemical detection (8) 8
liver (8) 8
oxidative stress (8) 8
performance liquid-chromatography (8) 8
protein (8) 8
proteins (8) 8
sarcosine (8) 8
adolescent (7) 7
agent ellipticine (7) 7
antibodies (7) 7
anticancer drug ellipticine (7) 7
cell biology (7) 7
cell cycle - drug effects (7) 7
dna adducts (7) 7
enzymes (7) 7
medicine (7) 7
metallothioneins (7) 7
neuroblastoma - drug therapy (7) 7
neuroblastoma - genetics (7) 7
neuroblastoma - metabolism (7) 7
neuroblastoma - pathology (7) 7
polymerase chain reaction (7) 7
prostate (7) 7
sudan-i (7) 7
urine (7) 7
amino acids (6) 6
anthracyclines (6) 6
biochemistry (6) 6
cancer therapies (6) 6
cell survival - drug effects (6) 6
delivery (6) 6
dose-response relationship, drug (6) 6
drug resistance, neoplasm (6) 6
endocrinology & metabolism (6) 6
epigenetics (6) 6
histone deacetylase inhibitors - pharmacology (6) 6
hypoxia (6) 6
kinases (6) 6
metabolites (6) 6
metallomics (6) 6
metallothionein - blood (6) 6
metastasis (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Molecular Sciences, ISSN 1661-6596, 07/2017, Volume 18, Issue 7, p. 1414
Carcinogenesis cannot be explained only by genetic alterations, but also involves epigenetic processes. Modification of histones by acetylation plays a key... 
Histone deacetylase inhibitors | Anti-angiogenic effect | Cell cycle arrest | Drug combinations | Histone deacetylases | Autophagy | Apoptosis | Cancer | HDAC INHIBITORS | autophagy | SUBEROYLANILIDE HYDROXAMIC ACID | HUMAN LEUKEMIA-CELLS | NITRIC-OXIDE SYNTHASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR-SUPPRESSOR GENES | apoptosis | VALPROIC ACID | cell cycle arrest | anti-angiogenic effect | CHEMISTRY, MULTIDISCIPLINARY | drug combinations | CELL LUNG-CANCER | EPITHELIAL-MESENCHYMAL TRANSITION | PHASE-II TRIAL | LONG NONCODING RNA | histone deacetylases | cancer | histone deacetylase inhibitors | Immunomodulation - drug effects | Apoptosis - drug effects | Humans | Angiogenesis Inhibitors - pharmacology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Autophagy - drug effects | Acetylation - drug effects | Animals | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Cycle Checkpoints - drug effects | Angiogenesis Inhibitors - therapeutic use | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Epigenesis, Genetic - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Gene Expression Regulation, Neoplastic - drug effects | Drug Evaluation, Preclinical
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2019, Volume 144, Issue 2, pp. 221 - 231
Histone methylation is important in the regulation of genes expression, and thus its dysregulation has been observed in various cancers. KDM5 enzymes are... 
KDM5 | chemoresistance | cancer cell epigenetics | histone demethylase | METHYLATION | TRANSCRIPTIONAL REPRESSION | H3K4 DEMETHYLASE | GENE | RBP2 | ONCOLOGY | PROSTATE-CANCER | RESISTANCE | TARGETS | JARID1B | Care and treatment | Drug resistance | Methylation | Cancer | Enzymes | Repressing | Deregulation | Transcription | Gene regulation | Chemoresistance | Gene expression | Suppressors | Lysine | Drug tolerance | DNA methylation | Histone H3
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2016, Volume 11, Issue 9, p. e0162916
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2019, Volume 144, Issue 2, pp. 221 - 231
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 01/2010, Volume 14, Issue 1‐2, pp. 426 - 433
Regulatory T cells (Treg) are important regulators of anti‐cancer immune responses, and an increase in Treg frequency was observed in the blood of cancer... 
regulatory T cells | tumour markers | early recurrence | head and neck squamous cell carcinoma | lymphocyte subpopulations | Early recurrence | Head and neck squamous cell carcinoma | Tumour markers | Regulatory T cells | Lymphocyte subpopulations | MEDICINE, RESEARCH & EXPERIMENTAL | CIRCULATION | LYMPHOCYTE SUBSETS | TUMOR | PERIPHERAL-BLOOD | OVARIAN-CARCINOMA | CELL BIOLOGY | CANCER-PATIENTS | IMMUNE-RESPONSES | ABSOLUTE COUNTS | DISEASE | EXPRESSION | Antigens, CD - immunology | Carcinoma, Squamous Cell - blood | T-Lymphocytes, Regulatory - metabolism | Prognosis | Humans | Middle Aged | Male | Carcinoma, Squamous Cell - immunology | Carcinoma, Squamous Cell - diagnosis | Young Adult | Head and Neck Neoplasms - immunology | Head and Neck Neoplasms - blood | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Head and Neck Neoplasms - diagnosis | Aged | Flow cytometry | Regulators | CD8 antigen | CD45RA antigen | Erythrocytes | Otolaryngology | Alcohol | Lymphocytes T | Biochemistry | Metastasis | Males | Blood | Metastases | Red blood cells | Immunology | Lymphocytes | Surgery | Hemoglobin | CD25 antigen | Diagnosis | Localization | CD56 antigen | Age | Antigens | Subpopulations | Squamous cell carcinoma | CD19 antigen | Blood & organ donations | Immunoregulation | Markers | CD3 antigen | Radiation therapy | Patients | CD4 antigen | CD16 antigen | Hospitals | Lymphocytes B | Medical prognosis | Head and neck cancer | Software | Tumors | Cancer
Journal Article
ACS Applied Materials & Interfaces, ISSN 1944-8244, 06/2016, Volume 8, Issue 23, pp. 14430 - 14441
Herein, we describe a novel approach for targeting of ubiquitous protein apoferritin (APO)-encapsulating doxorubicin (DOX) to prostate cancer using antibodies... 
Research | nanomedicine | targeted drug delivery | antibodies | doxorubicin | apoferritin | GOLD NANOPARTICLES | MEMBRANE DISRUPTION | PROTEIN-A | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | FC REGION | AFFINITY | THERANOSTICS | NANOSCALE | RECEPTORS | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, p. e0165830
Journal Article